Benitec Biopharma (BNTC) Net Cash Flow (2019 - 2025)

Benitec Biopharma (BNTC) has 7 years of Net Cash Flow data on file, last reported at $94.5 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 829.66% year-over-year to $94.5 million; the trailing twelve-month figure through Dec 2025 stood at $110.7 million (up 92.17% YoY), and the FY2025 full-year result was $46.9 million, down 3.27% from the prior year.
• Net Cash Flow rose to $94.5 million in Q4 2025, from -$3.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $94.5 million in Q4 2025 to a low of -$6.4 million in Q1 2024.
• A 5-year average of $8.7 million and a median of -$3.4 million in 2021 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow slumped 164.21% in 2022 and soared 1000.83% in 2024, its largest moves.
• Tracing BNTC's Net Cash Flow over 5 years: stood at -$3.3 million in 2021, then tumbled by 77.42% to -$5.9 million in 2022, then increased by 10.15% to -$5.3 million in 2023, then jumped by 293.25% to $10.2 million in 2024, then soared by 829.66% to $94.5 million in 2025.
• Business Quant data shows BNTC's Net Cash Flow at $94.5 million in Q4 2025, -$3.4 million in Q3 2025, and -$5.7 million in Q2 2025.